DAIC

DECEMBER 13, 2023

MILLER, PHD, LED THE DEVELOPMENT OF A NEW "ATHEROSCLEROSIS ATLAS" THAT DETAILS, AT THE LEVEL OF INDIVIDUAL CELLS, CRITICAL PROCESSES RESPONSIBLE FOR FORMING THE HARMFUL PLAQUE BUILDUP THAT CAUSES HEART ATTACKS, STROKES AND CORONARY ARTERY DISEASE.

Heart Attack 105

Heart Attack Heart attacks Atherosclerosis Stroke 105

Dr. Paddy Barrett

APRIL 26, 2024

Coronary artery disease is caused by the retention of a cholesterol particle in the artery wall. Insulin resistance and diabetes may not ‘ cause ’ coronary artery disease, but they are huge accelerants. If delaying the onset of major chronic disease is your goal. Timing Matters.

Heart Disease 92

Heart Disease Coronary Artery Disease Diabetes Genetic predisposition 92

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. We performed this retrospective cohort analysis to assess the impact of poorly controlled diabetes, defined as HbA1C of 9.0%

Outcomes 40

Outcomes Angioplasty Atrial Fibrillation Diabetes 40

Frontiers in Cardiovascular Medicine

FEBRUARY 12, 2024

Background There is mounting data supporting the use of drug-coated balloons (DCB) not only for treatment of in-stent restenosis (ISR), but also in native coronary artery disease. Angiograms and outcomes were independently adjudicated. So far, paclitaxel-coated balloons represented the mainstay DCBs. IQR 12; 14.2)

Coronary Artery Disease 59

Coronary Artery Disease Myocardial Infarction Stent Stents 59

DAIC

MARCH 20, 2024

Our efforts to expand therapeutic possibilities, underlined by the introduction of the Freesolve RMS for coronary artery disease treatment, will continue in the BTK indication with this groundbreaking innovation.” Eurointervention; 2023;18-online publish-ahead-of-print January 2023. 4 Seguchi M.,

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Coronary Artery Disease Technology 105

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. This study presented two patients with symptomatic common carotid artery occlusion (CCAO) who subsequently underwent subclavian‐carotid artery bypass surgery using the polytetrafluorethylene graft.

Outcomes 40

Outcomes Chest Pain Coronary Artery Disease Aortic 40

DAIC

JANUARY 15, 2024

Cardiac amyloidosis is a heterogeneous disease that results from the accumulation of abnormal proteins within the heart, impairing its ability to pump blood. Over time, the build-up of these proteins causes the heart muscle to stiffen, eventually leading to heart failure, which can have dire outcomes if not found early.

Ultrasound 119

Ultrasound Coronary Artery Disease Innovation Heart Failure 119

Dr. Paddy Barrett

OCTOBER 11, 2024

Between 2020 and 2023, the rates of obesity dropped by about 2% 2. Inflammation is a key driver of heart disease, specifically coronary artery disease. Sci Rep 13 , 20998 (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. 2023 Dec 14;389(24):2221-2232. Inflammation.

Obesity 60

Obesity Dementia Cancer Coronary Artery Disease 60

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart attacks Heart Attack Coronary Artery Disease 111

Journal of Cardiovascular Pharmacology

NOVEMBER 6, 2023

Abstract: Colchicine reduces atherothrombotic cardiovascular events in coronary artery disease (CAD) due to its anti-inflammatory effect. The primary outcome was the percentage change in hsCRP levels at the end of four weeks. The primary outcome was the percentage change in hsCRP levels at the end of four weeks.

Coronary Artery Disease 40

Coronary Artery Disease Outcomes 40

Dr. Paddy Barrett

OCTOBER 31, 2023

An elevated Lp(a) is a common genetic factor that is independently and causally related to premature coronary artery disease. The occurrence of disease in this instance is probabilistic, not deterministic. An elevated Lp(a) does increase the risk of early cardiovascular disease, but that risk is not set in stone.

Coronary Artery Disease 52

Coronary Artery Disease Heart Disease Atherosclerosis Cardiovascular Disease 52

Cardiology Update

FEBRUARY 14, 2024

In the early years of percutaneous coronary intervention (PCI), studies indicated a heightened risk of major adverse cardiac events (MACE) in patients with reduced left ventricular ejection fraction (LVEF), involving outcomes such as death, Q-wave myocardial infarction (MI), stent thrombosis, and repeat revascularization. Am Heart J.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Disease Thrombosis Research 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Outcomes of interest included symptomatic intracerebral hemorrhage (ICH), asymptomatic ICH, hemorrhagic transformation, mass effect and death. IntroductionThe risk of tandem occlusion treatment in the setting of intravenous thrombolysis is unclear.

Thrombolysis 40

Thrombolysis Angioplasty Hemorrhage Stents 40

Coronary Artery Disease Journal

MAY 29, 2024

Methods A total of 685 patients diagnosed with STEMI, treated with emergency PCI between January 2020 and June 2023, were included in this retrospective observational study. Objective This study aims to assess the relationship between serum iron levels and in-hospital mortality among patients with STEMI undergoing emergency PCI. μmol/L).

Myocardial Infarction 40

Myocardial Infarction Hospital STEMI Risk Factors 40

Dr. Anish Koka

MAY 16, 2023

Soviet biologist Trofim Lysenko famously rejected the objective reality of Mendelian genetics because it clashed with the Marxist philosophy that the environment, not genetics, was the primary determinant of outcomes. But what should matter is outcomes not diagnoses. Thanks for reading Dr. Anish Koka's Newsletter!

Chest Pain 52

Chest Pain Coronary Artery Disease Cancer Heart attacks 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Early diagnosis and appropriate treatment are crucial to reduce burden of poor outcomes and prevention of stroke.

Coronary Artery Disease 40

Coronary Artery Disease Blood Pressure Atherosclerosis Stroke 40

Dr. Paddy Barrett

SEPTEMBER 12, 2023

An elevated Lp(a) is independently and causally related to early: Coronary artery disease Stroke Peripheral Vascular Disease Aortic Stenosis For a more comprehensive review of what Lp(a) is and why it matters, I have covered this in much more detail here. Subscribe now 1 ODYSSEY Outcomes Committees and Investigators.

Cholesterol 52

Cholesterol Coronary Artery Disease Heart Disease Cardiovascular Disease 52

Dr. Smith's ECG Blog

SEPTEMBER 25, 2024

A 56 year old male with a history of diabetes, dyslipidemia, hypertension, and coronary artery disease presented to the emergency department with sudden onset weakness, fatigue, lethargy, and confusion. For more on use of Opiates with acute ischemic CP — See the January 6, 2023 post in Dr. Smith's ECG Blog ).

Chest Pain 108

Chest Pain Blog Hospital Tachycardia 108

Dr. Paddy Barrett

MAY 17, 2024

Regardless of what is driving the effect, it is clear that experiencing high levels of stress is associated with worse outcomes. 24% increased risk of coronary artery disease. While studies attempt to correct for these influences, it can be very hard to do. These findings have been replicated multiple times.

Heart Disease 85

Heart Disease Heart attacks Heart Attack Risk Factors 85

Dr. Smith's ECG Blog

SEPTEMBER 3, 2023

More past history: hypertension, tobacco use, coronary artery disease with two vessel PCI to the right coronary artery and circumflex artery several years prior. It is unknown when this pain recurred and became constant. He reports feeling nauseated with emesis. There is ischemic ST depression in V4-V6.

Chest Pain 131

Chest Pain Defibrillator STEMI Coronary Artery Disease 131

Dr. Smith's ECG Blog

NOVEMBER 15, 2023

Angiogram No obstructive epicardial coronary artery disease Cannot exclude non-ACS causes of troponin elevation including coronary vasospasm, stress cardiomyopathy, microvascular disease, etc. Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): The Past, Present, and Future Management [Internet].

Coronary Angiogram 102

Coronary Angiogram Plaque Thrombosis STEMI 102

Society of Thoracic Surgeons - Congenital

FEBRUARY 7, 2024

2024 STS Coronary Conference Submission Information gtrainyte Wed, 02/07/2024 - 14:48 Scroll to top Important Visit sts.org to access the submission site. All submissions should be related to surgery for coronary artery disease. No abstract will be considered with deferred outcomes data.

Education 40

Education Research Document Article 40

Dr. Paddy Barrett

SEPTEMBER 5, 2023

Share Let’s first state our goal when we are in the business of ‘Heart Disease Prevention’: To delay the onset of coronary artery disease (atherosclerosis/plaque) that might rupture and cause a heart attack. So, we now know that achieving fewer METs is associated with worse outcomes. Not any more.

Plaque 52

Plaque Heart attacks Heart Attack Exercise 52

Dr. Smith's ECG Blog

JANUARY 27, 2024

Old ‘NSTEMI’ A history of coronary artery disease and a stent to the same territory further increases pre-test likelihood of acute coronary occlusion, including in-stent thrombosis. This 4% is underestimation because it only included patients admitted as STEMI not those admitted as NSTEMI like the case above.

Chest Pain 102

Chest Pain STEMI Aneurysm Stent 102

Cardiometabolic Health Congress

JULY 25, 2023

This was a huge gap, because most patients with T2DM die from cardiovascular disease, and until recently, we had no means of preventing adverse cardiovascular events in these patients. Cardiovascular outcomes trials with SGLT-2 inhibitors have shown a strong effect in preventing major cardiovascular events (i.e., Lavie, Carl J.,

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52